SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19520407
Source:
http://linkedlifedata.com/resource/pubmed/id/19520407
Search
Subject
(
51
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0010583
,
umls-concept:C0026769
,
umls-concept:C0036043
,
umls-concept:C0087111
,
umls-concept:C0205329
pubmed:issue
12
pubmed:dateCreated
2009-12-17
pubmed:abstractText
Cyclophosphamide (CPM) is used empirically in the treatment of progressive multiple sclerosis. The purpose of this study was to evaluate its efficacy in naive patients with progressive multiple sclerosis.
pubmed:language
fre
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/2984779R
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0035-3787
pubmed:author
pubmed-author:AbouqalRR
,
pubmed-author:AhirAA
,
pubmed-author:Ait Ben HaddouEE
,
pubmed-author:BenomarAA
,
pubmed-author:ChatriHH
,
pubmed-author:El Alaoui TaoussiKK
,
pubmed-author:HassaniMM
,
pubmed-author:SlimaniCC
,
pubmed-author:YahyaouiMM
pubmed:issnType
Print
pubmed:volume
165
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1086-91
pubmed:meshHeading
pubmed-meshheading:19520407-Adult
,
pubmed-meshheading:19520407-Age of Onset
,
pubmed-meshheading:19520407-Antirheumatic Agents
,
pubmed-meshheading:19520407-Cyclophosphamide
,
pubmed-meshheading:19520407-Disabled Persons
,
pubmed-meshheading:19520407-Disease Progression
,
pubmed-meshheading:19520407-Female
,
pubmed-meshheading:19520407-Humans
,
pubmed-meshheading:19520407-Infusions, Intravenous
,
pubmed-meshheading:19520407-Male
,
pubmed-meshheading:19520407-Middle Aged
,
pubmed-meshheading:19520407-Multiple Sclerosis, Relapsing-Remitting
,
pubmed-meshheading:19520407-Retrospective Studies
,
pubmed-meshheading:19520407-Safety
,
pubmed-meshheading:19520407-Young Adult
pubmed:year
2009
pubmed:articleTitle
[Efficacy and safety of cyclophosphamide treatment in progressive multiple sclerosis].
pubmed:affiliation
Service de neurologie B et neurogénétique, hôpital des spécialités, Rabat, Maroc. elaitbenha@yahoo.fr
pubmed:publicationType
Journal Article
,
English Abstract